-
Mashup Score: 15A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer - 14 day(s) ago
Advances in Therapy – According to current guidelines, targeted therapy with a combination of BRAF plus MEK inhibitors is the preferred first-line treatment for patients with BRAF V600E-mutant…
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Jaida's Student Visionaries of the Year Fundraiser - 4 month(s) ago
This year, I’m so proud to be a part of the Leukemia & Lymphoma Society’s (LLS) Student Visionaries of the Year Campaign, working to raise as much as possible for LLS’s mission. I want to dedicate my time to LLS because of my grandpa and mom. When my mom was 16 years old, her father was diagnosed with cancer and unfortunately passed away because of it. My mom later went on to become an oncologist and continues to conduct research on leukemia and lymphoma in honor of her dad and my grandpa. They both motivate me to become part of LLS to help save lives. As a global leader in the fight against blood cancer, LLS: Funds cutting-edge research leading to breakthroughs in immunotherapy, genomics and personalized medicine that are improving and saving the lives of patients Provides free education and support for blood cancer patients and families, including personalized, one-on-one support, assistance with identifying and enrolling in clinical trials, and more. Mobilizes thousands of advocate
Source: events.lls.orgCategories: General Medicine News, Hem/OncsTweet-
Student Visionaries of the Year Washington DC It would mean so much if you could consider donating and/or sharing this link. My daughter is fundraising to help leukemia/lymphoma patients. #LLS #LeukemiaLymphoma https://t.co/XneFaq2nAr
-
-
Mashup Score: 5IASLC - Arabic UPDATED.mp3 - 5 month(s) ago
IASLC – Arabic UPDATED.mp3IASLC – Arabic UPDATED.mp3
Source: drive.google.comCategories: General Medicine News, Hem/OncsTweet-
IASLC - Arabic UPDATED.mp3 - Google Drive@iaslc #Arabic #lungcancer #Egypt #Saudi_Arabia @AsrarAlahmadi #Hamed_AlHusseini #Ahmed_Magdy_Rabie https://t.co/xNfUwpFmq8
-
-
Mashup Score: 2Nagla Karim - 6 month(s) ago
FacebookLog InLog InForgot Account?See more on FacebookSee more on FacebookEmail or phone numberPasswordLog InForgot password?orCreate new account
Source: www.facebook.comCategories: General Medicine News, Hem/OncsTweet-
Dedicated to #lungcancerawareness #Global @chrisdraft @IASLC @JCOGO_ASCO @ASCO @DrChoueiri @UCD_radonc wanting to raise awareness about lung cancer worldwide #savelives https://t.co/UprfOGxLc8
-
-
Mashup Score: 32023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond - 8 month(s) ago
Conference Chairs: Nagla Abdel Karim, MD, PhD and Vivek Subbiah, MDHonorary President: Alex Spira, MD, PhD, FACPDay 1 – September 29, 2023All times below are listed in Eastern Standard Time (EST).03:00 PM – 04:00 PM – REGISTRATION & NETWORKING04:00 PM – 04:05 PM – Welcome Note – Nagla Karim, MD04:05 PM – 04:15 PM – Binaytara Foundation’s Efforts in Improving Cancer Care Disparities – Binay Shah,…
Source: education.binayfoundation.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Please Register to Join us for this unique symposium @PatelOncology @VivekSubbiah @kgunturuMD @triparnasen @ChristianRolfo @StephenVLiu @SalmaJabbour1 https://t.co/fOdZM5fXbH
-
-
Mashup Score: 3Small Cell Lung Cancer Research Offering New Hope - 10 month(s) ago
Nagla Karim, MD is lead research that is offering new hope for patients living with small cell lung cancer.
Source: Inova NewsroomCategories: Hem/Oncs, Latest HeadlinesTweet-
Inova Lung Cancer Researcher Leads Study Offering New Hope for Small Cell Lung Cancer Patients - Inova Newsroom @InovaSchar @InovaHealth @LaurenByersMD @ReckampK @RamSubraMD @triparnasen https://t.co/B8bIrtmmUL
-
-
Mashup Score: 0
تقديم / أحمد شمس …. رئيس تحرير / فاطمة شعراوي …. اخراج / نهي السعيد
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
برنامج كلام من القلب د / نجلاء عبد الكريم ... د /نهي عوض .. السبت 1-7-2023 https://t.co/Ggf5xJSUgg via @YouTube My TV Interview @ the national channel in Cairo -Egypt prior to the ECRN/ESRN conference
-
-
Mashup Score: 0Log into Facebook | Facebook - 11 month(s) ago
Log into Facebook to start sharing and connecting with your friends, family, and people you know.
Source: FacebookCategories: Hem/Oncs, Latest HeadlinesTweet-
@ASCO @ASCOPost @SWOG #S1929 https://t.co/oMPfACDXUL
-
-
Mashup Score: 0Nagla Abdel Karim on Small Cell Lung Cancer SWOG S1929 Results on Atezolizumab Plus Talazoparib - The ASCO Post - 11 month(s) ago
2023 ASCO Annual Meeting Nagla Abdel Karim, MD, of the Inova Schar Cancer Institute, University of Virginia, discusses phase II data showing that maintenance atezolizumab plus talazoparib improved progression-free survival in Schlafen-11–selected patients with extensive-stage small cell lung cancer. This study demonstrated the feasibility of conducting biomarker-selected trials…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/n2Eyicduqf
-
-
Mashup Score: 0Patients With SLFN11-Expressing SCLC May Benefit From Immune Checkpoint Inhibitor Plus PARP Inhibitor - The ASCO Post - 12 month(s) ago
By The ASCO Post Staff Posted: 6/4/2023 9:00:00 AM Last Updated: 6/5/2023 12:43:51 PM Among patients with extensive-stage small cell lung cancer (SCLC) positive for expression of the Schlafen-11 gene (SLFN11), those who received maintenance treatment with the immune checkpoint inhibitor atezolizumab plus the…
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Patients With SLFN11-Expressing SCLC May Benefit From Immune Checkpoint Inhibitor Plus PARP Inhibitor - The ASCO Post https://t.co/A4B8GDx8EK
-
Hot of the Press: A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer | Advances in Therapy https://t.co/dyT4HE1ivy